La Rovere, M. T., and E. Traversi. “Prognostic Impact of Digoxin Use for Rate Control of Atrial Fibrillation in Patients ≥75 Years of Age”. Monaldi Archives for Chest Disease, vol. 88, no. 2, June 2018, doi:10.4081/monaldi.2018.954.